Results 161 to 170 of about 17,219 (260)
Advanced Healthcare Materials, EarlyView.This study presents a custom‐made soft pneumatic device (SPD) that mimics complex mechanical forces and fluid flow to enhance in vitro cell differentiation. It shows that low mechanotransduction promotes MSC differentiation into osteoprogenitor cells, while high mechanotransduction causes structural disruptions and cell detachment, providing new ...
Gwang‐Bum Im +9 more
wiley +1 more source
Experimentelle und klinische Beiträge zur Aethernarkose und zur Aether-Chloroform-Mischnarkose [PDF]
, 1902 Poppert
openalex +1 more source
Advanced Healthcare Materials, EarlyView.Progestin drugs are loaded into a mesoporous silicon dioxide host by melt‐infiltration. Drugs that decompose at or close to their melting point can be loaded by the addition of cholesterol, which acts as a melting point suppressor. High mass loading of the drug is achieved, and dissolution of the composite is controlled by the nanoscale properties of ...
Geoffrey Hollett +13 more
wiley +1 more source
ON CHLOROFORM AND OTHER ANÆSTHETICS THEIR ACTION AND ADMINISTRATION
, 1954 John Snow
openalex +1 more source
VII.—Action of chloroform and alkali hydroxides on the nitrobenzoic acids [PDF]
, 1898 Walter J. Elliott
openalex +1 more source
Advanced Healthcare Materials, EarlyView.The scaffold‐free Anchored Cell Sheet Engineering platform is used to create three‐dimensional (3D) in vitro models of skeletal muscle tissue that replicate key features of Duchenne and Myotonic dystrophies. These personalized tissue models, validated by histological, immunostaining, and proteomics analyses, accurately mimic disease phenotypes and ...
Alireza Shahin‐Shamsabadi +1 more
wiley +1 more source
A REPLY to the ACCUSATIONS MADE by Mr. LEONARD HILL Against the HYDERABAD CHLOROFORM COMMISSION [PDF]
, 1898 T. Lauder Brunton
openalex +1 more source
Advanced Healthcare Materials, EarlyView.This study develops itaconate‐based polymer microparticles (IA‐MPs) for macrophage‐targeted intracellular delivery, overcoming the limitations of traditional itaconate administration. IA‐MPs achieve controlled release through phagocytosis, reducing pro‐inflammatory cytokine expression and reprogramming macrophage metabolism toward glycolysis.
Kaitlyn E. Woodworth +10 more
wiley +1 more source